Finance

Lists
CAVA:NYSE
CAVA Group Inc
USD 53,64
-1,23%
(-0,67) 1D
USD 53,88
+0,45% (+0,24)
After hours
Closed: 9 Okt., 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAVA...
Open
USD 53,90
High
USD 54,17
Low
USD 53,26
Mkt. cap
6,27 mjd
Avg. vol.
3,46 m
Volume
1,66 m
52-wk high
USD 98,79
52-wk low
USD 43,41
Beta
1,80
Shares outstanding
116,81 m
No. of employees
13 k
Open
USD 53,90
High
USD 54,17
Low
USD 53,26
Mkt. cap
6,27 mjd
Avg. vol.
3,46 m
Volume
1,66 m
52-wk high
USD 98,79
52-wk low
USD 43,41
Beta
1,80
Shares outstanding
116,81 m
No. of employees
13 k
News stories
From web sources and news partners
About CAVA Group Inc
CEOBrett Schulman
Employees13,5 k
Founded2006
Headquarters-
Sector-
Websitecava.com
Analyst ratings
Based on 22 analysts giving stock ratings to CAVA in the past 3 months
Strong buy
Buy
18
Hold
4
Sell
0
12-month forecast
Based on 22 Wall Street analysts offering 12 month price targets for CAVA in the last 3 months.
Highest
Current USD 53,64
USD 110,00 (+105,07%)
Average
USD 89,26 (+66,41%)
Lowest
USD 58,00 (+8,13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jacob Aiken Phillips
Melius Research
Buy
Upgraded
USD 95,00
+77,1%
10/08/2026
John Ivankoe
J.P. Morgan
Buy
Maintained
USD 80,00
+49,1%
09/29/2026
Joe Feldman
Telsey Advisory
Buy
Maintained
USD 95,00
+77,1%
09/23/2026
Unknown Analyst
Seaport Global
Buy
Initiated
USD 58,00
+8,1%
09/15/2026
Eric Gonzalez
Seaport Global
Buy
Initiated
USD 58,00
+8,1%
09/15/2026
Logan Reich
RBC Capital
Buy
Maintained
USD 85,00
+58,5%
09/16/2026
Todd Brooks
StoneX
Buy
Maintained
USD 110,00
+105,1%
09/14/2026
Unknown Analyst
Robert W. Baird
Buy
Reiterated
USD 98,00
+82,7%
08/24/2026
Chris O`Cull
Robert W. Baird
Buy
Reiterated
USD 98,00
+82,7%
08/24/2026
Nick Setyan
Mizuho Securities
Hold
Maintained
USD 70,00
+30,5%
08/13/2026
Jim Sanderson
Northcoast Research
Hold
Upgraded
-
-
08/13/2026
Gregory Francfort
Guggenheim
Buy
Reiterated
USD 95,00
+77,1%
08/12/2026
Brian Vaccaro
Raymond James
Hold
Reiterated
-
-
08/12/2026
JP Wollam
Roth MKM
Buy
Reiterated
USD 95,00
+77,1%
08/12/2026
Danilo Gargiulo
Bernstein
Buy
Reiterated
USD 95,00
+77,1%
08/12/2026
Margaret-May Binshtok
Wolfe Research
Buy
Maintained
USD 82,00
+52,9%
08/11/2026
Jon Tower
Citi
Hold
Maintained
USD 79,00
+47,3%
08/11/2026
Dennis Geiger
UBS
Buy
Maintained
USD 90,00
+67,8%
08/12/2026
Brian Harbour
Morgan Stanley
Buy
Maintained
USD 90,00
+67,8%
08/12/2026
Brian Mullan
Piper Sandler
Buy
Maintained
USD 92,00
+71,5%
08/12/2026
Sara Senatore
Bank of America Securities
Buy
Reiterated
USD 107,00
+99,5%
08/13/2026
Sharon Zackfia
William Blair
Buy
Maintained
-
-
08/12/2026
Christopher Carril
KeyBanc
Buy
Maintained
USD 95,00
+77,1%
08/12/2026
Andrew Charles
TD Cowen
Buy
Maintained
USD 85,00
+58,5%
08/12/2026
Unknown Analyst
Freedom Capital Markets
Hold
Initiated
USD 95,00
+77,1%
06/30/2026
Sarang Vora
Telsey Advisory
Buy
Maintained
-
-
06/18/2026
Christine Dooley
Argus Research
Buy
Upgraded
USD 92,00
+71,5%
05/21/2026
Matt Curtis
D.A. Davidson
Hold
Maintained
USD 84,00
+56,6%
05/20/2026
Unknown Analyst
D.A. Davidson
Hold
Maintained
USD 84,00
+56,6%
05/20/2026
David Tarantino CFA
Robert W. Baird
Buy
Maintained
USD 98,00
+82,7%
05/20/2026
Jeff Bernstein
Barclays
Hold
Maintained
USD 74,00
+38%
05/20/2026
Unknown Analyst
Roth MKM
Buy
Initiated
USD 106,00
+97,6%
04/22/2026
Unknown Analyst
Raymond James
Hold
Reiterated
-
-
04/21/2026
Dana Telsey
Telsey Advisory
Buy
Maintained
USD 88,00
+64,1%
04/13/2026
Stephen J McManus
Exane BNP Paribas
Hold
Initiated
USD 91,00
+69,6%
03/30/2026
Greg Badishkanian
Wolfe Research
Buy
Initiated
USD 93,00
+73,4%
03/09/2026
Last report
11 Aug. 2026
Fiscal period
Q2 2026
USD 0,19 / USD 0,18
+3,13%beat
Revenue / Est. (USD)
368,44 m / 359,36 m
+2,52%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Okt. 2025
Des. 2025
Apr. 2026
Jul. 2026
Revenue
292,24 m
274,98 m
438,27 m
368,44 m
Cost of goods sold
181,66 m
178,79 m
269,09 m
225,97 m
Cost of revenue
181,66 m
178,79 m
269,09 m
225,97 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31,50 m
32,52 m
51,59 m
39,80 m
Operating expense
92,28 m
92,38 m
141,21 m
114,39 m
Total operating expenses
273,94 m
271,17 m
410,30 m
340,36 m
Operating income
18,30 m
3,82 m
27,98 m
28,08 m
Other non operating income
-30,00 k
-2,00 k
700,00 k
439,00 k
EBT including unusual items
20,67 m
6,08 m
30,04 m
30,58 m
EBT excluding unusual items
21,84 m
7,09 m
32,76 m
31,81 m
Income tax expense
5,92 m
1,16 m
6,47 m
7,56 m
Effective tax rate
28,64%
19,05%
21,55%
24,73%
Other operating expenses
38,21 m
36,84 m
57,99 m
46,89 m
Net income
14,75 m
4,92 m
23,57 m
23,02 m
Net profit margin
5,05%
1,79%
5,38%
6,25%
Earnings per share
0,12
0,04
0,20
0,19
Interest and investment income
3,58 m
3,27 m
4,08 m
3,29 m
Interest expense
-
-
-
-
Net interest expenses
3,58 m
3,27 m
4,08 m
3,29 m
Depreciation and amortization charges
17,63 m
18,41 m
25,47 m
20,97 m
EBITDA
35,92 m
22,22 m
53,44 m
49,04 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme